Reaktionsgleichung
C[O:2][C:3]([C:5]1[CH:6]=[C:7]([NH:11][C:12]2[N:17]=[C:16]([C:18]3[CH:23]=[CH:22][N:21]=[C:20]([NH:24][CH2:25][CH2:26][CH2:27][OH:28])[CH:19]=3)[CH:15]=[CH:14][N:13]=2)[CH:8]=[CH:9][CH:10]=1)=O.[NH2:29][CH2:30][CH2:31][CH2:32][NH2:33]>C(OCC)(=O)C>[NH2:29][CH2:30][CH2:31][CH2:32][NH:33][C:3]([C:5]1[CH:6]=[C:7]([NH:11][C:12]2[N:17]=[C:16]([C:18]3[CH:23]=[CH:22][N:21]=[C:20]([NH:24][CH2:25][CH2:26][CH2:27][OH:28])[CH:19]=3)[CH:15]=[CH:14][N:13]=2)[CH:8]=[CH:9][CH:10]=1)=[O:2]Komponenten
4
Edukt 2
Produkt 1
Reagenzien, Katalysatoren, Lösungsmittel 1
Versuchsvorschrift
100 mg (0.26 mmol) of N-[3-methoxycarbonyl-phenyl]-4-[2-(3-hydroxy-propyl-amino)-4-pyridyl]-2-pyrimidineamine and 0.5 ml of 1,3-diamino-propane are stirred for 24 h at 90° and then diluted with 20 ml of ethyl acetate and extracted with 2×10 ml of sodium chloride solution. The organic phase is dried, concentrated and crystallised from methylene chloride/diethyl ether to give N-[3-{N-(3-amino-propyl)-aminocarbonyl}-phenyl]-4-[2-(3-hydroxy-propyl-amino)-4-pyridyl]-2-pyrimidineamine;
Aufarbeitung
- extractionextracted with 2×10 ml of sodium chloride solution
- customThe organic phase is dried
- concentrationconcentrated
- customcrystallised from methylene chloride/diethyl ether
Quellen und Nachweise
- ORD-Eintrag
- ord-e95dea12efcf46abb4f2455c2c2c6569
- Quelldatensatz
- uspto-grants-1998_03
- Patentnummer
- US05728708
Verknüpfte Notizen
Wird geladen…